Health Care: Drugs

Mylan NV (MYL: NASDAQ)

$39.72 n/a | n/a%
05/26/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 39.72
52 Week High 50.40
52 Week Low 33.60
Avg. Daily Vol. (Mil) 5.74
Beta (3 year) 1.46
Share Related Items
Mkt Cap (Mil) 21,289.19
Shares Out (Mil) 535.98
Float (Mil) 473.94
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.00
Current Ratio 1.60
LT Debt/ Equity 0.64
Total Debt / Equity 0.76
Valuation Ratios
Price Earnings 23.30
Price/Sales 2.26
Price/Book 2.18
Price/Cash Flow 11.30
Per Share Data
Earnings 1.70
Sales 17.59
Book Value 18.22
Cash Flow 3.51
Business Summary
Mylan NV is a generic pharmaceutical manufacturer which develops, licenses, manufactures, markets and distributes generic, over-the-counter (OTC) products in a variety of dosage forms and therapeutic categories.
General Information
Building 4, Trident Place
Mosquito Way
Hatfield, He AL10 9UL
www.mylan.com
Industry : Drugs
Sector: Health Care
Employees: 35000
CEO: Heather Bresch
Short Interest
Current Month (Mil) 16.98
Previous Month (Mil) 17.98
Short Interest Ratio (Days) 3.20
Management Effectiveness
Return on Equity 8.70
Return on Assets 3.80
Return on Investments 5.30
Profitability
Gross Margin 55.70
EBIT Margin 13.30
Profit Margin 9.00

Portfolios with MYL

Latest MYL Headlines from TheStreet

More Financial News for MYL

Press Releases for MYL

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter